PHRX - Pharmagen, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue4,813.0484,260.61862.75
Cost of Revenue1,767.8362,996.106453.553
Gross Profit3,045.2121,264.504409.197
Operating Expenses
Research Development---
Selling General and Administrative5,204.243,360.759691.741
Non Recurring1,195.8811,195.8811,195.881
Total Operating Expenses---
Operating Income or Loss-3,611.67-2,096.255-282.544
Income from Continuing Operations
Total Other Income/Expenses Net361.99690.00590.005
Earnings Before Interest and Taxes-2,992.913-2,006.25-282.544
Interest Expense3,007.701765.01814.266
Income Before Tax-6,000.614-2,771.268-296.81
Income Tax Expense---
Minority Interest---
Net Income From Continuing Ops-6,000.614-2,771.268-296.81
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-6,000.614-2,771.268-296.81
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-6,457.614-2,771.268-296.81